Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33259728)

  • 21. Identification and Verification of Core Genes in Colorectal Cancer.
    Xu H; Ma Y; Zhang J; Gu J; Jing X; Lu S; Fu S; Huo J
    Biomed Res Int; 2020; 2020():8082697. PubMed ID: 32462020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Key mRNAs and Pathways in Colorectal Cancer.
    Hou X; Hou N; Fu J; He X; Xiong H; Xie W; Jia G; Zuo X; Qin X; Pang M
    Nutr Cancer; 2021; 73(6):1040-1046. PubMed ID: 32586129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of key genes in colorectal cancer using random walk with restart.
    Cui X; Shen K; Xie Z; Liu T; Zhang H
    Mol Med Rep; 2017 Feb; 15(2):867-872. PubMed ID: 28000901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated regulatory mechanisms of miRNAs and targeted genes involved in colorectal cancer.
    Wang J; Yu H; Ye L; Jin L; Yu M; Lv Y
    Int J Clin Exp Pathol; 2015; 8(1):517-29. PubMed ID: 25755742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Key Gene Targets for Sensitizing Colorectal Cancer to Chemoradiation: an Integrative Network Analysis on Multiple Transcriptomics Data.
    Manoochehri H; Jalali A; Tanzadehpanah H; Taherkhani A; Saidijam M
    J Gastrointest Cancer; 2022 Sep; 53(3):649-668. PubMed ID: 34432208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between PPP2CA expression and colorectal cancer prognosis tumor marker prognostic study.
    Yong L; YuFeng Z; Guang B
    Int J Surg; 2018 Nov; 59():80-89. PubMed ID: 30296597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integration of gene expression data identifies key genes and pathways in colorectal cancer.
    Hozhabri H; Lashkari A; Razavi SM; Mohammadian A
    Med Oncol; 2021 Jan; 38(1):7. PubMed ID: 33411100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights regarding novel biomarkers and the pathogenesis of primary colorectal carcinoma based on bioinformatic analysis.
    Wang YR; Meng LB; Su F; Qiu Y; Shi JH; Xu X; Luo QF
    Comput Biol Chem; 2020 Apr; 85():107229. PubMed ID: 32058945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Key Genes in Colorectal Cancer Regulated by miR-34a.
    Wang T; Xu H; Liu X; Chen S; Zhou Y; Zhang X
    Med Sci Monit; 2017 Dec; 23():5735-5743. PubMed ID: 29197895
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Yang Q; Qi M; Chen Y; Tian S; Liao F; Dong W
    DNA Cell Biol; 2021 Jul; 40(7):921-935. PubMed ID: 34042518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioinformatic Identification of Hub Genes and Analysis of Prognostic Values in Colorectal Cancer.
    Lei X; Jing J; Zhang M; Guan B; Dong Z; Wang C
    Nutr Cancer; 2021; 73(11-12):2568-2578. PubMed ID: 33153324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects.
    Huang TH; Mokgautsi N; Huang YJ; Wu ATH; Huang HS
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenoma to carcinoma: A portrait of molecular and immunological profiles of colorectal sporadic tumors.
    Elsayed I; Li L; Sheahan K; Moran B; Bakheit S; Wang X
    Int Immunopharmacol; 2021 Nov; 100():108168. PubMed ID: 34562842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Hub Gene TIMP1 and Relative ceRNAs Regulatory Network in Colorectal Cancer.
    Qin YF; Li GM; Wang G; Kong DJ; Wang HD; Zhao YM; Hao JP; Qin H; Sun DQ; Wang H
    Ther Clin Risk Manag; 2021; 17():889-901. PubMed ID: 34475758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Novel miRNAs, Targeting Genes, Signaling Pathway, and the Small Molecule for Overcoming Oxaliplatin Resistance of Metastatic Colorectal Cancer.
    Misbah M; Kumar M; Lee KH; Shen SC
    Biomed Res Int; 2022; 2022():3825760. PubMed ID: 36193307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer.
    Yu C; Hong H; Lu J; Zhao X; Hu W; Zhang S; Zong Y; Mao Z; Li J; Wang M; Feng B; Sun J; Zheng M
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806905. PubMed ID: 30336768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptome analysis in primary colorectal cancer tissues from patients with and without liver metastases using next-generation sequencing.
    Wang S; Zhang C; Zhang Z; Qian W; Sun Y; Ji B; Zhang Y; Zhu C; Ji D; Wang Q; Sun Y
    Cancer Med; 2017 Aug; 6(8):1976-1987. PubMed ID: 28745433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated Analysis of the Gene Expression Changes During Colorectal Cancer Progression by Bioinformatic Methods.
    Zhang Y; Wu W; Qu H
    J Comput Biol; 2019 Oct; 26(10):1168-1176. PubMed ID: 31246501
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.